Please assess the completion status of the following clinical trial:

Trial Title: Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 18-60 years of age~* ASA 1-3~* Elective surgical procedure~Exclusion Criteria:~* BMI ≥ 45~* Pregnancy~* Requirement for RSI or awake intubation~* Suspected or known difficult airway~* Contraindication to IV in either upper extremity~* Chronic pain syndrome including fibromyalgia~* Use of opioids, NSAIDs, or other analgesics within 24 hours (including preoperative PO Celebrex, Lyrica, Tylenol, etc.)~* Any use of opioids in the past three months~* Significant cardiopulmonary or hepatic dysfunction~* Hypersensitivity to study medications

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: ACTIVE_COMPARATOR): 1 mg/kg lidocaine to a max of 100 mg
- Esmolol (Type: ACTIVE_COMPARATOR): 0.5 mg/kg esmolol to a max of 50 mg
- Placebo (Type: PLACEBO_COMPARATOR): Saline water

Based on this trial design, predict the completion outcome and termination type (if applicable).